DeepMed Research

HAMAD MEDICAL CORPORATION

🇶🇦Qatar

Country: 🇶🇦Qatar

Ownership: -

Established: 1979-01-01

Employees: -

Market Cap: -

Website: https://www.hamad.qa

Clinical Trials

An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.

Phase 4

Completed

Conditions: Stroke, Ischemic

Interventions: Drug: Enteric Coated Aspirin Tablet
Drug: Plain Aspirin

First Posted Date: 2020-04-02

Last Posted Date: 2020-04-02

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 42

Registration Number: NCT04330872

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods

Not Applicable

Completed

Conditions: Infection, Bacterial

Interventions: Drug: Vancomycin-traditional dosing
Drug: Vancomycin- Trough-only based dosing

First Posted Date: 2020-03-05

Last Posted Date: 2022-08-15

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 65

Registration Number: NCT04297176

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Synergistic Effect Of Parenteral Diclofenac And Paracetamol In The Pain Management Of Acute Limb Injuries

Phase 4

Completed

Conditions: Musculoskeletal Injury

Interventions: Drug: Diclofenac and Paracetamol

First Posted Date: 2019-12-16

Last Posted Date: 2023-03-01

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 162

Registration Number: NCT04199572

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

An Evaluation Study to Identify the Effectiveness of Clinical Supervision With Regards to Work-related Strain, Sense of Coherence, Increased Cultural Sensitivity and the Impact on Patient's Care: A Prospective Longitudinal Study in Mental Health Services in Qatar

Not Applicable

Completed

Conditions: Sense of Coherence
Work Related Stress
Clinical Supervision
Cultural Sensitivity

Interventions: Other: Clinical Supervision

First Posted Date: 2019-12-12

Last Posted Date: 2022-03-29

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 136

Registration Number: NCT04196751

Locations: 🇶🇦
Mental Health Services, Hamad Medical Corporation, Doha, Qatar

Switch to Oral Antibiotics in Gram-negative Bacteremia

Not Applicable

Completed

Conditions: Escherichia Coli Bacteremia
Enterobacter Bacteraemia
Serratia Bacteraemia
Proteus Bacteraemia
Klebsiella Bacteraemia
Citrobacter Bacteraemia

Interventions: Other: IV antimicrobial therapy
Other: Step down to oral antimicrobial therapy

First Posted Date: 2019-10-31

Last Posted Date: 2023-08-14

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 176

Registration Number: NCT04146922

Locations: 🇰🇼
Farwaniya Hospital, Kuwait, Kuwait
🇧🇭
Bahrain Defense Forces Hospital, Manama, Bahrain
🇶🇦
Hamad Medical Corporation, Doha, Qatar

and more 4 locations

Hybrid Closed Loop System for Patients on Multiple Daily Insulin Injections

Not Applicable

Conditions: Type 1 Diabetes

First Posted Date: 2019-10-31

Last Posted Date: 2021-02-21

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 40

Registration Number: NCT04145804

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Pilot Study Comparison Of Intravenous Ibuprofen And Intravenous Paracetamol In Management Of Pediatric Fever

Early Phase 1

Completed

Conditions: Fever

Interventions: Drug: Intravenous Ibuprofen

First Posted Date: 2019-10-11

Last Posted Date: 2024-08-14

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 147

Registration Number: NCT04123717

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

EtCO2 for Monitoring and Predicting Severity of DKA in Pediatric Emergency, Doha, Qatar.

Recruiting

Conditions: Diabetes Mellitus

First Posted Date: 2019-10-10

Last Posted Date: 2024-02-28

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 150

Registration Number: NCT04121572

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Impact of Body Composition and Exercise on Clinical, Metabolic and Molecular Parameters in Type 2 Diabetics in Qatar

Not Applicable

Conditions: Type 2 Diabetes

Interventions: Behavioral: 10-week exercise programme based on aerobic interval and resistance training

First Posted Date: 2019-09-06

Last Posted Date: 2019-10-07

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 60

Registration Number: NCT04081064

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Qatar Diabetes Mobile Application Trial

Not Applicable

Conditions: Type2 Diabetes Mellitus

Interventions: Device: Droobi
Other: Standard of care

First Posted Date: 2019-06-26

Last Posted Date: 2020-02-17

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 180

Registration Number: NCT03998267

Locations: 🇶🇦
Hamad General Hospital, Doha, Qatar

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy